These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38769647)

  • 1. Resolve and dissolve-An ultrasound-guided investigation on the effects of hyaluronidase on different soft tissue fillers.
    Bravo BSF; Cavalcante T; Silveira C; Bravo LG; Zafra MC; Elias MC
    J Cosmet Dermatol; 2024 Oct; 23(10):3173-3181. PubMed ID: 38769647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional hyaluronidase injection to relieve non-hyaluronic acid filler-induced vascular adverse events.
    Kadouch J; Schelke L; Groh O; Sokol V; Velthuis P
    Int J Dermatol; 2024 Sep; 63(9):1252-1255. PubMed ID: 38955457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of Hylauronic Acid Fillers Using Hyaluronidase in an In Vivo Model.
    Ferraz RM; Sandkvist U; Lundgren B
    J Drugs Dermatol; 2018 May; 17(5):548-553. PubMed ID: 29742187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Correlation Between Hyaluronic Acid Filler and Hyaluronidase.
    Hwang E; Song YS
    J Craniofac Surg; 2017 May; 28(3):838-841. PubMed ID: 28085765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rehabilitation of the Dysmorphic Lower Eyelid From Hyaluronic Acid Filler: What to Do After a Good Periocular Treatment Goes Bad.
    Skippen B; Baldelli I; Hartstein M; Casabona G; Montes JR; Bernardini F
    Aesthet Surg J; 2020 Jan; 40(2):197-205. PubMed ID: 30877762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Scoping Review of Hyaluronidase Use in Managing the Complications of Aesthetic Interventions.
    Borzabadi-Farahani A; Mosahebi A; Zargaran D
    Aesthetic Plast Surg; 2024 Mar; 48(6):1193-1209. PubMed ID: 36536092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The duration of hyaluronidase and optimal timing of hyaluronic acid (HA) filler reinjection after hyaluronidase injection.
    Kim HJ; Kwon SB; Whang KU; Lee JS; Park YL; Lee SY
    J Cosmet Laser Ther; 2018 Feb; 20(1):52-57. PubMed ID: 29199877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound to improve the safety of hyaluronic acid filler treatments.
    Schelke LW; Decates TS; Velthuis PJ
    J Cosmet Dermatol; 2018 Dec; 17(6):1019-1024. PubMed ID: 30084182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of Visual Loss With Retrobulbar Hyaluronidase Injection After Hyaluronic Acid Filler.
    Chesnut C
    Dermatol Surg; 2018 Mar; 44(3):435-437. PubMed ID: 28877147
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse Events Associated with Hyaluronic Acid Filler Injection for Non-surgical Facial Aesthetics: A Systematic Review of High Level of Evidence Studies.
    Kyriazidis I; Spyropoulou GA; Zambacos G; Tagka A; Rakhorst HA; Gasteratos K; Berner JE; Mandrekas A
    Aesthetic Plast Surg; 2024 Feb; 48(4):719-741. PubMed ID: 37563436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronidase: What is your fear?
    Bravo BSF; Bianco S; Bastos JT; Carvalho RM
    J Cosmet Dermatol; 2021 Oct; 20(10):3169-3172. PubMed ID: 34242464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early ultrasound for diagnosis and treatment of vascular adverse events with hyaluronic acid fillers.
    Schelke LW; Velthuis P; Kadouch J; Swift A
    J Am Acad Dermatol; 2023 Jan; 88(1):79-85. PubMed ID: 31325548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Hyaluronidase-Mediated Degradation Kinetics of Commercially Available Hyaluronic Acid Fillers In Vitro.
    Faivre J; Wu K; Gallet M; Sparrow J; Bourdon F; Gallagher CJ
    Aesthet Surg J; 2024 May; 44(6):NP402-NP410. PubMed ID: 38366708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of hyaluronic acid fillers used to enhance overall lip fullness: A systematic review of clinical studies.
    Stojanovič L; Majdič N
    J Cosmet Dermatol; 2019 Apr; 18(2):436-443. PubMed ID: 30636365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase.
    Buhren BA; Schrumpf H; Bölke E; Kammers K; Gerber PA
    Eur J Med Res; 2018 Aug; 23(1):37. PubMed ID: 30122153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers.
    Cavallini M; Gazzola R; Metalla M; Vaienti L
    Aesthet Surg J; 2013 Nov; 33(8):1167-74. PubMed ID: 24197934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations.
    Smith KC
    Dermatol Online J; 2008 Aug; 14(8):3. PubMed ID: 19061563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on: Efficacy of Percutaneous Intraarterial Facial/Supratrochlear Arterial Hyaluronidase Injection for Treatment of Vascular Embolism Resulting From Hyaluronic Acid Filler Cosmetic Injection.
    DeLorenzi C
    Aesthet Surg J; 2022 May; 42(6):656-659. PubMed ID: 35442425
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of Intra-arterial and Subcutaneous Testicular Hyaluronidase Injection Treatments and the Vascular Complications of Hyaluronic Acid Filler.
    Wang M; Li W; Zhang Y; Tian W; Wang H
    Dermatol Surg; 2017 Feb; 43(2):246-254. PubMed ID: 27930375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of Post-filler Vision Loss and Skin Ischaemia with High-Dose Pulsed Hyaluronidase Injections.
    Wibowo A; Kapoor KM; Philipp-Dormston WG
    Aesthetic Plast Surg; 2019 Oct; 43(5):1337-1344. PubMed ID: 31236610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.